References
- WagnerAKGravesAJReissSKLecatesRZhangFRoss-DegnanDAccess to care and medicines, burden of health care expenditures, and risk protection: results from the World Health SurveyHealth Policy20111002–315115820828854
- ErlyanaEDamrongplasitKKMelnickGExpanding health insurance to increase health care utilization: will it have different effects in rural vs urban areas?Health Policy20111002–327328121168932
- SinaikoADRosenthalMBIncreased price transparency in health care – challenges and potential effectsN Engl J Med20113641089189421388306
- DugelPUTongKBDevelopment of an activity-based costing model to evaluate physician office practice profitabilityOphthalmology2011118120320820709400
- GinsburgPBRapidly evolving physician-payment policy – more than the SGRN Engl J Med2011364217217621142529
- GinsburgPBWide variation in hospital and physician payment rates evidence of provider market powerRes Briefs20101611121117341
- CooperRKramerTRRevenue-based cost assignment: a potent but hidden threat to the survival of the multispecialty medical practiceAcad Med201085353854720182135
- CooperRKramerTRRevenue-based cost assignment: the hidden and inaccurate equal-profit-margin assumptionMGMA Connex200884447
- CooperRKramerTRRBRVS costing: the inaccurate wolf in expensive sheep’s clothingJ Health Care Finance200834361818468375
- GrandlichCUsing activity-based costing in surgeryAORN J200479118919214763586
- LievensYvan den BogaertWKestelootKActivity-based costing: a practical model for cost calculation in radiotherapyInt J Radiat Oncol Biol Phys200357252253512957266
- EmmettDForgetRThe utilization of activity-based cost accounting in hospitalsJ Hosp Mark Public Relations2005152798916201419
- CaoPToyabeSKurashimaSOkadaMAkazawaKA modified method of activity-based costing for objectively reducing cost drivers in hospitalsMethods Inf Med200645446246916964366
- SturzlingerHGenserDFroschlBEvaluation of optical coherence tomography in the diagnosis of age related macula degeneration compared with fluorescence angiographyGMS Health Technol Assess20073Doc0221289936
- PatelJJMendesMABounthavongMChristopherMLBoggieDMorrealeAPCost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov modelJ Eval Clin Pract9162010 [Epub ahead of print]
- MyungJSBhatnagarPSpaideRFLong-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticumRetina201030574875519996818
- SpaideRFThe as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment systemAm J Ophthalmol200914811319540983
- BrownGBrownMMLet us wake the nation on the treatment for age-related macular degenerationCurr Opin Ophthalmol201021316917120397317
- BrownMMLuoBBrownHCBrownGCComparative effectiveness: its role in the healthcare systemCurr Opin Ophthalmol200920318819419425205
- ShipmanSALanJChangCHGoodmanDCGeographic maldistribution of primary care for childrenPediatrics20111271192721172992
- BrownMMBrownGCLeiskeHBLieskePAHealthcare costs, buyer alertCurr Opin Ophthalmol201122314915121460725
- CruessAFZlatevaGXuXEconomic burden of bilateral neovascular age-related macular degeneration: multi-country observational studyPharmacoeconomics2008261577318088159
- CruessAZlatevaGXuXRochonSBurden of illness of neovascular age-related macular degeneration in CanadaCan J Ophthalmol200742683684318026200
- CunninghamPJFellandLEGinsburgPBPhamHHQualitative methods: a crucial tool for understanding changes in health systems and health care deliveryMed Care Res Rev2011681344021075752